- ISIN
- US8051111016
- CUSIP
- 805111101
- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Jun 1, 2017
Highlights
- Market Cap
- $1.44B
- Enterprise Value
- $1.43B
- EPS (TTM)
- -$0.57
- Gross Profit (TTM)
- -$425.00K
- EBITDA (TTM)
- -$133.25M
- Year Range
- $1.98 - $7.01
- Target Price
- $10.00
- ROA (TTM)
- -58.42%
- ROE (TTM)
- -73.55%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
SVRA Performance Chart
Savara Inc. (SVRA) is down 5.6% since the beginning of the year. At $6 per share, SVRA is trading 18.8% below its 52-week high of $7. Investors who bought $1,000 worth of SVRA shares 5 years ago would now be looking at an investment worth $3,308.
Loading charts...
Returns By Period
Savara Inc. (SVRA) has returned -5.64% so far this year and 176.21% over the past 12 months.
Savara Inc.
- 1D
- 3.45%
- 1M
- 13.35%
- YTD
- -5.64%
- 6M
- -12.06%
- 1Y
- 176.21%
- 3Y*
- 25.77%
- 5Y*
- 27.03%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
SVRA Monthly Returns History
Based on dividend-adjusted daily data since Jun 1, 2017, SVRA's average daily return is +0.17%, while the average monthly return is +4.06%. At this rate, an investment would double in approximately 1.5 years.
Historically, 47% of months were positive and 53% were negative. The best month was Dec 2019 with a return of +255.6%, while the worst month was Jun 2019 at -78.1%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 7 months.
On a daily basis, SVRA closed higher 46% of trading days. The best single day was Dec 30, 2019 with a return of +183.8%, while the worst single day was Jun 13, 2019 at -75.2%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -10.45% | 11.48% | -9.30% | -4.03% | -0.76% | 9.42% | -5.64% | ||||||
| 2025 | -12.05% | -7.78% | 11.24% | 15.52% | -28.75% | -0.00% | 13.60% | 26.64% | 8.84% | 16.25% | 51.57% | -4.13% | 96.42% |
| 2024 | 5.11% | 2.23% | -1.39% | -8.03% | -10.70% | -1.47% | 14.14% | -7.17% | -0.70% | -14.27% | -7.57% | -8.63% | -34.68% |
| 2023 | 67.74% | -3.85% | -22.00% | -3.59% | 46.28% | 16.18% | 12.05% | 1.12% | 4.42% | -3.17% | 5.19% | 22.08% | 203.23% |
| 2022 | -0.81% | -5.69% | 12.93% | -9.92% | 11.02% | 16.03% | 6.58% | -11.73% | 8.39% | -20.65% | 28.46% | -1.90% | 25.00% |
| 2021 | 33.04% | 11.11% | 22.35% | -8.65% | -5.26% | -5.56% | -24.71% | 21.09% | -10.97% | -15.94% | -6.90% | 14.81% | 7.83% |
Benchmark Metrics
Savara Inc. has an annualized alpha of 36.93%, beta of 0.84, and R2 of 0.03 versus S&P 500 Index. Calculated based on daily prices since June 01, 2017.
- This stock participated in 120.48% of S&P 500 Index downside but only 77.81% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.03 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 36.93%
- Beta
- 0.84
- R²
- 0.03
- Upside Capture
- 77.81%
- Downside Capture
- 120.48%
Return for Risk
Risk / Return Rank
SVRA ranks 92 for risk / return — in the top 92% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Savara Inc. (SVRA) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SVRA | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.09 | ||
| Sortino ratioReturn per unit of downside risk | +0.81 | ||
| Omega ratioGain probability vs. loss probability | 1.42 | 1.37 | +0.06 |
| Calmar ratioReturn relative to maximum drawdown | 5.54 | 2.78 | +2.76 |
| Martin ratioReturn relative to average drawdown | 11.28 | 12.44 | -1.16 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Savara Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Savara Inc. was 95.75%, occurring on Nov 14, 2019. The portfolio has not yet recovered.
The current Savara Inc. drawdown is 66.05%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2019 bear market2019 | -95.75%Nov 2019 | 1y 10mo | — | 8y 6moDec 2017 - now |
2017 bear market2017 | -25.22%Aug 2017 | 1mo 28d | 19d | 2mo 17dJun 2017 - Sep 2017 |
2017 correction2017 | -13.51%Oct 2017 | 1mo | 19d | 1mo 19dSep 2017 - Nov 2017 |
2017 pullback2017 | -9.68%Sep 2017 | 3d | 3d | 6dSep 2017 - Sep 2017 |
2017 pullback2017 | -6.59%Jun 2017 | 4d | 2d | 6dJun 2017 - Jun 2017 |
Drawdown Indicators
| SVRA | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.75% | -56.78% | -38.97% |
Max Drawdown (1Y)Largest decline over 1 year | -31.99% | -9.10% | -22.89% |
Max Drawdown (3Y)Largest decline over 3 years | -65.30% | -18.90% | -46.40% |
Max Drawdown (5Y)Largest decline over 5 years | -65.30% | -25.43% | -39.87% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -66.05% | -1.80% | -64.25% |
Average DrawdownAverage peak-to-trough decline | -71.80% | -10.71% | -61.09% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.70% | 2.03% | +13.67% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Savara Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Savara Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for SVRA in comparison with other companies in the Biotechnology industry. Currently, SVRA has a P/B value of 8.2. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with SVRA
Add Savara Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with SVRA